1-7 of 7
Feng Qian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A070: Time-Dependent Oxidation and Aggregation of Vimentin upon Binding by β-lap Induced Immunogenic Cell Death

Feng Qian, Lei Dou, Kaixin Wang, Yi Xia, Zhidong Chen, Yumeng Zu, Shuang Xi
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement_2): A070.
https://doi.org/10.1158/1538-7445.PANCREATIC24-A070
Published: 15 September 2024
View article titled, Abstract A070: Time-Dependent Oxidation and Aggregation of Vimentin upon Binding by β-lap Induced Immunogenic Cell Death
Journal Articles

Abstract 3624: Improved intratumor drug delivery and therapeutic efficacy in pancreatic cancer by albumin-Cisplatin complex

Chao Kong, Junxiao Ye, Zhengsheng Liu, Weijian Kong, Mengnan Sun, Huiqin Liu, Fang Yuan, Feng Qian
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3624.
https://doi.org/10.1158/1538-7445.AM2019-3624
Published: 01 July 2019
View article titled, Abstract 3624: Improved intratumor drug delivery and therapeutic efficacy in pancreatic cancer by albumin-Cisplatin complex
Journal Articles

Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2–MEK1/2–ERK1/2 Signaling

Cheng-Dong Ji, Yan-Xia Wang, Dong-Fang Xiang, Qiang Liu, Zhi-Hua Zhou, Feng Qian, Lang Yang, Yong Ren, Wei Cui, Sen-Lin Xu, Xi-Long Zhao, Xia Zhang, Yan Wang, Peng Zhang, Ji-Ming Wang, You-Hong Cui, Xiu-Wu Bian
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (11): 3041–3053.
https://doi.org/10.1158/0008-5472.CAN-17-3776
Published: 31 May 2018
View article titled, Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2–MEK1/2–ERK1/2 Signaling
Open the PDF for Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2–MEK1/2–ERK1/2 Signaling in another window
Includes: Supplementary data
Journal Articles

Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

Feng Qian, Jeannine Villella, Paul K. Wallace, Paulette Mhawech-Fauceglia, Joseph D. Tario, Jr., Christopher Andrews, Junko Matsuzaki, Danila Valmori, Maha Ayyoub, Peter J. Frederick, Amy Beck, Jianqun Liao, Richard Cheney, Kirsten Moysich, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5498–5504.
https://doi.org/10.1158/0008-5472.CAN-08-2106
Published: 01 July 2009
View article titled, Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Open the PDF for Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Identification of a novel HLA-A24-restricted CTL epitope from NY-ESO-1 following immunization of ovarian cancer patients with a peptide of dual MHC Class I and II specificities

Feng Qian, Sacha Gnjatic, Eric Hoffman, Jonathan Skipper, Shashikant Lele, Lloyd J. Old, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1212.
Published: 01 May 2005
View article titled, Identification of a novel HLA-A24-restricted CTL epitope from NY-ESO-1 following immunization of ovarian cancer patients with a peptide of dual MHC Class I and II specificities
Journal Articles

T heper type1(Th1)/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401+ patients with epithelial ovarian cancer

Feng Qian, Sacha Gnjatic, Darren Santiago, Cathy Grande, Sally Schneider, Bernadette Keitz, Gerd Ritter, Shashikant Lele, Ashwani Sood, Lloyd J. Old, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 292.
Published: 01 April 2004
View article titled, T heper type1(Th1)/Th2 CD4<sup>+</sup> T cell responses against NY-ESO-1 in HLA-DPB1*0401<sup>+</sup> patients with epithelial ovarian cancer
Journal Articles

NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer

Kunle Odunsi, Achim A. Jungbluth, Elisabeth Stockert, Feng Qian, Sacha Gnjatic, Jonathan Tammela, Marilyn Intengan, Amy Beck, Bernadette Keitz, Darren Santiago, Barbara Williamson, Matthew J. Scanlan, Gerd Ritter, Yao-Tseng Chen, Deborah Driscoll, Ashwani Sood, Shashikant Lele, Lloyd J. Old
Journal: Cancer Research
Cancer Res (2003) 63 (18): 6076–6083.
Published: 01 October 2003
View article titled, NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer
Open the PDF for NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer in another window